European drug regulators approved the higher-dose version of Wegovy in February. Called Wegovy HD, the higher-dose drug helped participants in a study lose about 19% of their body weight, or almost 47 ...
The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.
The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 ...
Amgen stock holds above key SMAs as strong drug sales, biosimilars, and MariTide pipeline momentum offset looming patent losses and pricing headwinds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results